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3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis.
Background. Heat-sterilized, single-chambered, glucose-
containing peritoneal dialysis solutions promote neutrophil
apoptosis and impair the peritoneal antibacterial response. It
has been proposed that glucose degradation products may be
responsible for this effect. However, the precise contribution
of individual glucose degradation products had not been ad-
dressed.
Methods. The effect of individual glucose degradation prod-
ucts on apoptosis in cultured human neutrophils and peripheral
blood mononuclear cells was studied.
Results. Peritoneal dialysis solutions with a high content of
both glucose and glucose degradation products accelerated
neutrophil and mononuclear cell apoptosis. Among the differ-
ent glucose degradation products, 3,4-di-deoxyglucosone-3-ene
(3,4-DGE) accelerated apoptosis in neutrophils and periph-
eral blood mononuclear cells at concentrations (25 lmol/L)
in the range found in heat-sterilized, single-chambered, 4.25%
glucose peritoneal dialysis fluids. Apoptosis induced by 3,4-
DGE was caspase-dependent and could be prevented by the
broad-spectrum caspase inhibitor benzyloxycarbonyl-Val-Ala-
DL-Asp-fluoromethylketone (zVAD-fmk). By contrast, no cy-
totoxicity was observed following the addition of methylglyoxal,
acetaldehyde, formaldehyde, or 3-deoxyglucosone at concen-
trations found in peritoneal dialysis solutions.
Conclusion. 3,4-DGE appears to be the main proapop-
totic factor in high glucose peritoneal dialysis solutions. 3,4-
DGE may impair peritoneal defenses by accelerating leukocyte
apoptosis.
Some long-term peritoneal dialysis complications
may be favored by the poor biocompatibility of peri-
toneal dialysis solutions. Peritonitis is one of the main
complications of peritoneal dialysis. Peritoneal dialysis
solutions impair the peritoneal antibacterial inflamma-
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tory response through actions on leukocytes. Among
these actions, heat-sterilized, single-chambered, glucose-
containing peritoneal dialysis solutions have been shown
to promote death of monocytes and neutrophils [1, 2].
Apoptosis is an active form of cell death, that, if dysregu-
lated, can lead to disease [3]. Apoptosis is characterized
by the activation of intracellular lethal molecules. Cas-
pases are a family of intracellular cysteine proteases that
behave as activators and effectors of apoptosis and play
a central role in the process [3]. Induction of leukocyte
apoptosis is one of the mechanisms of peritoneal dialysis
solution-related impairment in peritoneal defense [4, 5].
Indeed, commercial, heat-sterilized, glucose-containing
peritoneal dialysis solutions accelerate apoptosis and
impair the antibacterial capacity of cultured human neu-
trophils [4]. Rescue from apoptosis by the use of caspase
inhibitors restores the defensive function of neutrophils
in culture [4]. These results have been confirmed in
vivo in an experimental model of Staphylococcus aureus
peritonitis [5]. Glucose was the most obvious candidate
to account for the cytotoxicity of peritoneal dialysis
fluids as it promotes apoptosis in several cell types,
including vascular endothelium, renal tubular cells, and
the blastocyst [6–8]. However, a proapoptotic activity of
glucose itself in the leukocyte peritoneal dialysis system
was excluded, as the addition of exogenous glucose to
commercial 1.5% glucose-containing peritoneal dialysis
solutions did not reproduce the proapoptotic effect
induced by 4.25% glucose peritoneal dialysis solutions
[4]. Lactate content and pH were further excluded as the
cause of cytotoxicity [4]. A role of glucose degradation
products (GDPs) in peritoneal dialysis fluid–mediated
cytotoxicity had been previously demonstrated [9].
GDPs are produced during the heat sterilization pro-
cedure of peritoneal dialysis fluids, especially if this
is carried out at a neutral pH [9]. Thus, traditional
commercial peritoneal dialysis fluids had a low pH in
order to minimize GDP generation. However, even
when sterilized under low pH conditions, a significant
amount of GDPs were formed [abstract; Tauer A, et al,
Perit Dial Int 20:142, 2000] [9, 10] that were thought to
result in toxicity. Newer, double- or triple-chambered
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peritoneal dialysis solutions allow the separation of a
low pH glucose chamber from the electrolyte chamber
during sterilization, thus decreasing GDP formation. The
contents from the different chambers are mixed just prior
to infusion into the peritoneum. These new solutions
have a low GDP content [abstract; Tauer A, et al, Perit
Dial Int 20:142, 2000] [9, 10]. In this regard, low GDP,
high-glucose peritoneal dialysis solutions did not display
the cytotoxicity associated with high GDP, high-glucose
peritoneal dialysis solutions [4]. The hypothesis was put
forward that the high GDP content of peritoneal dialysis
solutions might be responsible for the proapoptotic
effect [4]. However, confirmation of the hypothesis
called for the identification of the precise GDPs that
accelerate neutrophil apoptosis. We now report that
3,4-di-deoxyglucosone-3-ene (3,4-DGE) accelerates
apoptosis in human leukocytes to a extent similar to
commercial, single-chambered, high-glucose peritoneal
dialysis solutions.
METHODS
Isolation and culture of leukocytes
Leukocytes were isolated from peripheral blood of
healthy volunteers by Ficoll gradient centrifugation
(Rafer SL, Zaragoza, Spain) [4]. The study was approved
by the Ethics Committee of the Fundacio´n Jime´nez Dı´az.
Briefly, each 10 mL sample of heparinized blood was
diluted with 10 mL of 0.9% NaCl, underlayered with
10 mL of Ficoll, and spun at 1800 rpm for 30 minutes at
room temperature. The platelet layer was discarded, and
the mononuclear cell layer was washed twice and then
resuspended in serum-free RPMI 1640 (Life Technolo-
gies, Grand Island, NY, USA), 100 U/mL penicillin, and
100 lg/mL streptomycin. The buffy coat was mixed with
2.5% gelatin in phosphate-buffered saline (PBS). After
15 minutes at 37◦C, the supernatant was harvested and
spun at 2500 rpm for 15 minutes. Residual erythrocytes
were lysed with hypotonic saline and neutrophils were
resuspended in serum-free RPMI 1640. The percentage
of apoptotic neutrophils right after isolation was <1%,
as assessed by flow cytometry of permeabilized, propid-
ium iodide–stained cells. Neutrophils and mononuclear
cells were incubated in serum-free RPMI 1640 or peri-
toneal dialysis solutions with or without addition of spe-
cific GDPs for 15 minutes. Then, the culture media were
diluted 1:1 by the addition of RPMI 1640 in order to neu-
tralize the acid pH and reproduce the physiologic condi-
tions in peritoneal dialysis. The incubation was prolonged
for 24 hours. This time point was chosen based on previ-
ous experience on the kinetics of cell death in cultured
neutrophils [4].
Commercial, heat-sterilized, single-chambered,
lactate-buffered, pH 5.5, peritoneal dialysis solutions
that contained 1.5% or 4.25% glucose (Fresenius Med-
ical Care, Bad Homburg, Germany) were used. These
solutions will be referred to throughout the text as
commercial 1.5% or 4.25% glucose peritoneal dialysis
solutions. They have a higher GDP content than newer,
double-chambered, neutral pH, peritoneal dialysis
solutions [abstract; Tauer A, et al, Perit Dial Int 20:142,
2000].
Glucose degradation products and caspase inhibitors
The following GDPs were studied: methylglyoxal
(Sigma Chemical Co., St. Louis, MO, USA) (15 lmol/L
in RPMI and in commercial peritoneal dialysis solu-
tions); acetaldehyde (Sigma Chemical Co.) (200 lmol/L
in RPMI and 50 lmol/L in peritoneal dialysis solu-
tions); formaldehyde (Sigma Chemical Co.) (15 lmol/L in
RPMI and 10 lmol/L in peritoneal dialysis solutions); 3-
deoxyglucosone (obtained from Paul J. Thornalley, Uni-
versity of Essex, Colchester, UK) (275 lmol/L in RPMI
and in peritoneal dialysis solutions); and 3,4-DGE (gener-
ously provided by Anders Weislander, Gambro Lundia,
Sweden) (25 lmol/L in RPMI, and 12 to 25 lmol/L in
peritoneal dialysis solutions). The amount of GDP to be
added was estimated from the literature [abstract; Tauer
A, et al, Perit Dial Int 20:142, 2000] [9–12] and was in-
tended to raise the GDP concentration in RPMI and
1.5% glucose peritoneal dialysis solution to levels found
in commercial 4.25% glucose peritoneal dialysis solu-
tion [abstract; Tauer A, et al, Perit Dial Int 20:142, 2000]
[9–12].
The caspase inhibitory peptide benzyloxycarbonyl-
Val-Ala-DL-Asp-fluoromethylketone (zVAD-fmk)
(Bachem, Bubendorf, Switzerland) was dissolved in
methanol and added at the time of dilution of the
peritoneal dialysis solution [4]. Final concentration
of methanol was <0.01%. This concentration did not
modulate cell death.
Assessment of cell death and apoptosis
For quantification of cell death, 150,000 cells were
seeded in 12-well plates (Beckton-Dickinson, Franklin
Lakes, NJ, USA) under the experimental conditions. At
defined time points, the cells were harvested by pool-
ing nonadherent cells with adherent cells, which were
detached by gentle trypsinization. Apoptosis was quan-
tified by flow cytometry assessment of DNA content of
5000 cells [4]. Pooled attached and detached cells were
resuspended in a cell permeabilization buffer containing
100 lg/mL propidium iodide, 10 lg/mL RNAse A, and
0.05% NP-40 in PBS, incubated at 4◦C for 1 hour, and
analyzed on the FACScan using Lysis II software. By per-
meabilizing the cells propidium iodide was allowed access
to both dead and live cells. The absolute number of cells
with decreased DNA staining (A0), comprising apoptotic
cells with fragmented nuclei, was counted.
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To assess the typical nuclear changes seen in apop-
tosis, cells were fixed and stained with propidium io-
dide. After fixation, propidium iodide stains both live
and dead cells. Cells were plated onto Labtek(tm) slides
(Nunc Inc., Naperville, IL, USA). The cells were stained
with propidium iodide basically as previously described
[4]. Briefly, the slides were fixed for 20 minutes in 1:1
methanol/acetone at −20◦C, washed with PBS, and then
stained for 30 minutes at 37◦C in 0.1 lg/mL propidium
iodide, 100 lg/mL RNAse A in PBS, pH 7.2. Finally, the
slides were washed with PBS and coverslips mounted us-
ing a 90% glycerol solution. The slides were examined
with a fluorescence microscope using an ultraviolet light
source filtered for propidium iodide. Two hundred cells
were examined in adjacent microscopic fields starting
from the upper left corner of the slide.
For assessment of internucleosomal genomic DNA
fragmentation, a characteristic of apoptosis, 106 neu-
trophils were cultured for 24 hours under different ex-
perimental conditions, washed three times in PBS, and
lysed in 20 lL of lysis buffer [50 mmol/L Tris-HCl,
20 mmol/L ethylenediaminetetraacetic acid (EDTA),
and 0.5% sodium laurylsarkosine, pH 8.0] and incubated
30 minutes at 4◦C. The samples were centrifuged at
12,000 rpm for 30 minutes at 4◦C, and the supernatant was
incubated for 1 hour with 5 lL proteinase K (1 mg/mL)
at 50◦C, and then for another hour at 50◦C with 5 lL
RNAse A (10 ng/mL). Finally, the temperature was in-
creased to 70◦C for 10 minutes and the loading buffer
was added. Samples were separated in a 1.5% agarose
gel and stained with ethidium bromide.
Caspase-3 activity
Neutrophils were incubated with RPMI, peritoneal
dialysis solutions, 3,4-DGE and 200 lmol/L zVAD, or
vehicle for 24 hours. Caspase-3 activity (MBL, Nagoya,
Japan) was measured following the manufacturer’s in-
structions [13]. In brief, cell extracts (50 lg of protein)
were incubated in half-area 96-well plates at 37◦C with
200 lmol/L DEVD-pNA peptide in a total volume of 100
lL. The pNA light emission was quantified using a spec-
trophotometer plate reader at 405 nm. Comparison of
the absorbance of pNA from an apoptotic sample with
an uninduced control allows determination of the fold
increase in caspase activity.
Statistics
Results are expressed as mean ± SD. Significance at
the 95% level was established using Mann-Whitney test
for comparing two groups and Kruskal-Wallis for more
than two groups by means of the SigmaStat statistical
software (Jandel, San Rafael, CA, USA). Four indepen-
dent experiments with neutrophils from different donors
were performed.
RESULTS
3,4-DGE accelerates human neutrophil apoptosis
We confirmed that exposure of neutrophils to com-
mercial 4.25% glucose peritoneal dialysis solutions in-
creases the spontaneous rate of apoptosis (Fig. 1). In
order to pinpoint the GDP that might be responsible
for this effect, different GDPs were added to culture
medium or to 1.5% glucose peritoneal dialysis fluid in or-
der to raise the concentration of the GDP to that found
in 4.25% glucose peritoneal dialysis fluids. Furthermore,
additional GDPs were added to 4.25% glucose peritoneal
dialysis fluids in order to further increase the concentra-
tion of the GDP. This strategy failed to reveal a signifi-
cant increase of apoptosis induced by clinically relevant
concentrations of methylglyoxal (15 lmol/L), acetalde-
hyde (200 lmol/L), formaldehyde (15 lmol/L), and 3-
deoxyglucosone (275 lmol/L) (Fig. 1). By contrast, a
dose-response lethal effect could be observed when 3,4-
DGE was added to neutrophils (Fig. 2A). Internucleoso-
mal DNA degradation was present in cells cultured under
those conditions (Fig. 2B). The microscopic examination
of neutrophils exposed to 3,4-DGE revealed an increased
percentage of cells showing typical morphologic features
of apoptosis, such as decreased cell and nuclear size and
nuclear condensation and fragmentation (Fig. 3C).
Caspases are mediators of neutrophil apoptosis induced
by 3,4-DGE
We then addressed whether caspases mediate apop-
tosis induced by 3,4-DGE, as they mediate commercial,
high-glucose peritoneal dialysis solution-induced apop-
tosis [4]. Both spontaneous neutrophil apoptosis and
apoptosis accelerated by 3,4-DGE were characterized
by activation of caspase-3, the main effector caspase
(Fig. 3A). Similar extent of caspase-3 activation was ob-
served in cells exposed to either RPMI or 1.5% glucose
peritoneal dialysis solution with exogenous 3,4-DGE and
in cells exposed to 4.25% glucose peritoneal dialysis so-
lution. zVAD-fmk, a broad-spectrum, caspase inhibitor,
decreased the degree of caspase-3 activation (Fig. 3A).
zVAD had previously been shown to decrease 4.25%
glucose peritoneal dialysis solution induced apoptosis [4].
In addition, it also decreased 3,4-DGE–induced apopto-
sis of neutrophils (Fig. 3B and C). Absence of morpho-
logic features of apoptosis was noted in zVAD-treated
cells (Fig. 3C).
3,4-DGE induces caspase-mediated peripheral blood
mononuclear cell apoptosis
We now report that commercial, high GDP, 4.25% glu-
cose peritoneal dialysis solutions also promote periph-
eral blood mononuclear cell apoptosis. The lethal effect
is quantitatively smaller, although proportionally similar
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Fig. 1. Several glucose degradation products (GDPs) do not accelerate neutrophil apoptosis. Neutrophils were cultured in the presence of culture
medium (RPMI) or peritoneal dialysis solutions. Different concentrations of GDPs were added to RPMI or to 1.5% glucose peritoneal dialysis fluid
in order to raise the concentration of the GDP to that found in commercial 4.25% glucose peritoneal dialysis fluids. Additional GDPs were added
to 4.25% glucose peritoneal dialysis fluids in order to further increase the concentration of the GDP. (A) Methylglyoxal, 15 lmol/L, added to RPMI
and peritoneal dialysis solutions. (B) Formaldehyde, 15 lmol/L, to RPMI and 10 lmol/L to peritoneal dialysis solutions. (C) Acetaldehyde, 200
lmol/L, to RPMI and 50 lmol/L to peritoneal dialysis solutions. ∗P = 0.05 vs. 1.5% glucose (G). (D) 3-deoxyglucosone (3-DG), 275 lmol/L, to RPMI
and to peritoneal dialysis solutions. ∗P < 0.001 vs. RPMI. (E) Methylglyoxal, formaldehyde, and 3-deoxyglucosone (GDP mixture). Apoptotic cells
were identified as hypodiploid cells by flow cytometry. These GDPs did not significantly and consistently increase apoptosis. Mean ± SD of four
independent experiments.
(60% to 90% increase in apoptosis over culture medium
controls 4.25% glucose 3.7 ± 0.3 vs. RPMI 2.0 ± 0.1%
apoptosis at 24 hours) (P = 0.017) (Fig. 4) to cell death
observed in neutrophils. Addition of exogenous 3,4-DGE
to RPMI culture medium or 1.5% glucose peritoneal
dialysis solution also increased the rate of mononuclear
cell apoptosis to levels similar to those induced by high-
glucose peritoneal dialysis solutions with similar intrinsic
3,4-DGE concentration (Fig. 4A). This effect was atten-
uated by caspase inhibition (Fig. 4B and C).
DISCUSSION
We have identified 3,4-DGE as a GDP that acceler-
ates apoptosis in human leukocytes cultured both in cell
culture medium and in the presence of peritoneal dial-
ysis solutions. The fact that the proapoptotic effect is
quantitatively and qualitatively similar to that induced
by commercial, high GDP, high-glucose peritoneal dialy-
sis solutions suggests that 3,4-DGE is the main cytotoxic
GDP responsible for this adverse effect of peritoneal dial-
ysis solutions.
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Fig. 2. 3.4-di-deoxyglucosone-3-ene (3,4-
DGE) accelerates neutrophil apoptosis.
(A) Quantification of flow cytometry re-
sults:effect of dose. Cells were cultured for
24 hours in the presence of commercial
peritoneal dialysis (PD) solutions/3,4-DGE.
Mean ± SD of four independent experiments.
∗P = 0.05; ∗∗P < 0.01 vs. 0 lmol/L 3,4-DGE.
(B) Internucleosomal DNA degradation was
observed in neutrophils aged 24 hours ex vivo,
the intensity been increased in peritoneal
dialysis solution and 3,4-DGE–exposed cells.
MWM is molecular weight markers.
Commercial peritoneal dialysis solutions containing
4.25% glucose and high GDP concentration accelerated
the rate of spontaneous neutrophil apoptosis [4]. Prema-
ture neutrophil apoptosis compromises the antibacterial
potential of these leukocytes in culture and in vivo [4,
5]. We have now expanded these observations to periph-
eral blood mononuclear cells. The lethal effect of com-
mercial, high-glucose peritoneal dialysis solutions was
not accounted for by the low pH nor by the high osmo-
lality or glucose, and should be ascribed to additional
factors related to the high glucose levels [4]. GDPs are
produced from glucose in the course of heat-sterilization
of single-chambered, glucose-containing peritoneal dial-
ysis solutions, especially in the presence of high glucose
concentrations. In this regard, the presence of increased
concentrations of GDPs in peritoneal dialysis fluids has
been linked to cytotoxicity, although the mechanisms of
death were not addressed [4, 9]. However, GDPs are a
heterogeneous group of compounds that may have het-
erogeneous biologic roles. As an example, acetaldehyde
prevents the formation of advanced glycation end prod-
ucts (AGEs) and may have a cardioprotective effect [14].
The earliest identified GDPs, such as methylglyoxal, ac-
etaldehyde, and formaldehyde, did not display cytotoxi-
cty for a fibroblastic cell line at the concentrations found
in peritoneal dialysis fluids [15, 16]. The concentration
of these GDPs has to be at least three times, and in
most cases more than ten times, higher than those ac-
tually found in the peritoneal dialysis fluids in order to
induce cytotoxicity. As shown in this paper, these com-
pounds are neither cytotoxic for human leukocytes. 3-
deoxyglucosone promotes apoptosis in a variety of cell
types [17]. In human neutrophils, a trend toward in-
creased apoptosis was noted. However, this proapoptotic
effect did not account for the lethality of peritoneal dial-
ysis solutions with a high GDP content, as it was mild
and of dubious clinical significance. A mixture of several
GDPs that included 3-deoxyglucosone also failed to sig-
nificantly accelerate death rate.
More recently, 3,4-DGE was shown to be the main cy-
totoxic compound from peritoneal dialysis fluid for a cul-
tured fibroblast cell line [12]. 3,4-DGE had previously
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Fig. 3. 3,4-di-deoxyglucosone-3-ene (3,4-
DGE)–induced neutrophil apoptosis is
caspase-dependent. (A) Activation of
caspase-3 was quantified by a colorimetric
assay, based on the cleavage of a peptide
target. Cells were cultured for 24 hours in
the presence of culture medium (RPMI) or
commercial peritoneal dialysis solutions/3,4-
DGE (25 lmol/L added to RPMI and 12
lmol/L to peritoneal dialysis solutions) and
200 lmol/L benzyloxycarbonyl-Val-Ala-
DL-Asp-fluoromethylketone (zVAD-fmk)
or vehicle. zVAD-fmk prevents caspase-3
activation. Mean ± SD of four independent
experiments. ∗P = 0.049 vs. other groups;
∗∗P = 0.04 vs. zVAD. (B) Prevention of
3,4-DGE–induced neutrophil apoptosis by
zVAD-fmk. Cells were cultured for 24 hours
in the presence of RPMI or commercial
peritoneal dialysis solutions/3,4-DGE and
200 lmol/L zVAD-fmk or vehicle. Apoptosis
was quantified by flow cytometry. Mean ±
SD of four independent experiments. ∗P <
0.01 vs. 3,4 DGE; ∗∗P < 0.01 vs. 4.25%. (C)
Flow cytometry diagrams of permeabilized,
propidium iodide–stained cells. Note the
decrement of the A0 peak corresponding to
apoptotic, hypodiploid cells in the presence
of zVAD-fmk. Inset: Examples of nuclear
morphology. Note the apoptotic morphology
in 3,4-DGE exposed cells (arrow). Propid-
ium iodide staining of permeabilized cells
(original magnification ×1000).
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Fig. 4. 3,4-di-deoxyglucosone-3-ene
(3,4-DGE) induces caspase-dependent
mononuclear cell apoptosis. (A) Dose-
response curve. Cells were cultured for 24
hours in the presence of culture medium
(RPMI) or commercial peritoneal dialysis
solutions/3,4-DGE (25 lmol/L added to
RPMI and 12 lmol/L to peritoneal dialysis
solutions). Mean ± SD of four independent
experiments. ∗P = 0.03 vs. 1.5% glucose; ∗∗P
< 0.001 vs. 1.5% glucose; ∗∗∗P < 0.001 vs.
0 lmol/L 3,4-DGE. (B) Protective effect of
caspase inhibition. Cells were cultured for 24
hours in the presence of RPMI or commercial
peritoneal dialysis solutions/3,4-DGE (25
lmol/L added to RPMI and 12 lmol/L to
peritoneal dialysis solutions) and 200 lmol/L
benzyloxycarbonyl-Val-Ala-DL-Asp-
fluoromethylketone (zVAD-fmk) or vehicle.
Mean ± SD of four independent experiments.
∗P < 0.01 vs. 3,4-DGE; ∗∗P < 0.001 vs. 4.25%
glucose. (C) Flow cytometry diagrams of
permeabilized, propidium iodide–stained
cells. Note the disappearance of the A0 peak
corresponding to apoptotic, hypodiploid
cells in the presence of zVAD-fmk. Inset:
Examples of nuclear morphology. Note the
apoptotic morphology in 3,4-DGE and 4.25%
glucose peritoneal dialysis solution exposed
cells (arrow). Propidium iodide staining of
permeabilized cells (original magnification
×400).
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been isolated from a brown seaweed with immunosup-
pressive activity [18]. 3,4-DGE had marked suppressive
effects on T-cell proliferation, antibody production
from B cells, and interleukin (IL)-1 production from
macrophages, as well as immunosuppressive properties
in vivo [18]. Our results expand these observations,
and identify a possible mechanism of the cytotoxicity
and immunosuppressive actions of 3,4-DGE. Indeed,
the present data implicate 3,4-DGE in the induction
of apoptosis on cell targets, neutrophils and peripheral
blood mononuclear cells, that are relevant for peritoneal
physiopathology. The concentration of 3,4-DGE in heat-
sterilized, single-chambered peritoneal dialysis fluid has
been estimated to be 10 and 22 lmol/L for 1.5% and 4%
glucose containing peritoneal dialysis solution [12]. The
addition of 3,4-DGE to either control culture medium
or 1.5% glucose peritoneal dialysis solution in order to
reach the concentration found in high-glucose peritoneal
dialysis solution resulted in increased caspase-3 activity
and apoptosis rate to values similar to those induced by
commercial, high GDP, 4.25% glucose peritoneal dial-
ysis solution. These data, in addition to previous evi-
dence for a role for GDPs in this adverse effect derived
from the fact that accelerated apoptosis is not induced by
low-GDP, high-glucose peritoneal dialysis solutions [4],
strongly suggest that 3,4-DGE is responsible for the accel-
erated leukocyte apoptosis induced by high-glucose peri-
toneal dialysis solutions. Accelerated leukocyte apoptosis
may impair the peritoneal defense, as demonstrated in an
experimental model of S. aureus peritonitis [5]. The ad-
verse effects of 3,4-DGE in the peritoneum may not be
limited to leukocytes or cell death, as 3,4-DGE also im-
pairs the repair of the loss of integrity of the mesothelial
monolayer [19].
From a clinical point of view, these results suggest
that low 3,4-DGE containing peritoneal dialysis solutions
may have a favorable profile regarding infectious com-
plications, such as peritonitis incidence or severity. The
concentration of 3,4-DGE in peritoneal dialysis fluids
increases when these are stored at warmer temperatures
[20]. This may result in doubling of the 3,4-DGE concen-
tration within a 2-week time frame when storage temper-
ature is increased from 25◦C to 40◦C [20]. The evidence
that 3,4-DGE promotes leukocyte apoptosis would pre-
dict that the incidence and/or severity of peritonitis may
increase during the summer months, especially in warmer
countries. This, indeed, has been the case in reports from
Hong-Kong and Korea [21–23].
Peripheral blood mononuclear cells are mainly lym-
phocytes. The role of the lymphocyte in peritoneal
defense has not been adequately studied. There are dif-
ferent functional types of lymphocytes. In our cell culture
experiments, 3,4-DGE doubled the rate of apoptosis of
mononuclear cells. Although it is difficult to extrapolate
to the in vivo situation, this increase in cell death may
result in significant premature loss of lymphocytes. The
disruption of the immune system might be even greater
if only one of the functional populations of lymphocytes
were the target of the cytotoxic effect. Clearly more stud-
ies are needed to further clarify this point. However, the
fact that 3,4-DGE is immunosuppressive in vivo [18] sug-
gests that the effect on mononuclear cell survival may be
of clinical significance.
The possible impact of this information may extend
beyond the field of peritoneal dialysis. The concentration
of several GDPs, such as 3-deoxyglocosone and methyl-
glyoxal is increased in diabetic individuals [24, 25]. It is
well known that diabetics have impaired antibacterial de-
fenses and the risk of dying from an infection increases
with worse glycemic control [26]. In particular, diabetics
have an impaired ability to eradicate certain microorgan-
isms such as S. aureus [27]. The clearance of this bacteria
is accelerated in experimental peritonitis when leukocyte
apoptosis induced by high-GDP peritoneal dialysis so-
lutions is inhibited [5]. Vancomycin-resistant S. aureus
were originally described in diabetic dialysis patients,
including peritoneal dialysis patients that were un-
able to control a S. aureus infection despite long-term
antibiogram-directed therapy [27]. While the serum or
tissue levels of 3,4-DGE in diabetics are not known, the
hypothesis that high 3,4-DGE levels may be generated
systemically or locally within infected tissue in diabetics
with poor glycemic control merits to be further tested.
CONCLUSION
Our findings suggest that 3,4-DGE is the main factor
responsible for the acceleration of neutrophil and pe-
ripheral blood mononuclear cells apoptosis induced by
commercial, high-GDP, high-glucose peritoneal dialysis
solutions. Although the pathogenesis of the immune de-
fect in diabetics is complex, a role of 3,4-DGE in diabetic
complication should be explored.
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